智慧隱形眼鏡市場規模、佔有率及成長分析(按類型、應用、最終用戶和地區分類)-2026-2033年產業預測
市場調查報告書
商品編碼
1897549

智慧隱形眼鏡市場規模、佔有率及成長分析(按類型、應用、最終用戶和地區分類)-2026-2033年產業預測

Smart Contact Lenses Market Size, Share, and Growth Analysis, By Type (Electrodes-Based Lenses, Sensors-Based Lenses), By Application (Continuous Glucose Monitoring, Intraocular Pressure Monitoring), By End-User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 217 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球智慧隱形眼鏡市場規模預計在 2024 年達到 67.8 億美元,從 2025 年的 74.1 億美元成長到 2033 年的 150.9 億美元,在預測期(2026-2033 年)內複合年成長率為 9.3%。

智慧隱形眼鏡市場正經歷顯著成長,這主要得益於人們對創新醫療解決方案日益成長的需求,尤其是在糖尿病患者群體中。這些先進的隱形眼鏡能夠測量淚液中的葡萄糖水平和眼內壓,並配備用於數據傳輸的內建無線晶片,採用RFID技術供電。醫療意識的提高、人口老化以及糖尿病相關性青光眼和白內障等慢性疾病的流行是推動市場擴張的關鍵因素。此外,對高效、非侵入性診斷工具的需求不斷成長也提升了智慧隱形眼鏡對使用者的吸引力。儘管存在這些有利趨勢,但高昂的實施成本可能會阻礙其廣泛應用。預計智慧隱形眼鏡技術的持續發展和相關人員的投資將在不久的將來對市場動態產生積極影響。

全球智慧隱形眼鏡市場促進因素

隱形眼鏡領域的快速發展帶動了全球智慧隱形眼鏡市場的顯著成長。智慧隱形眼鏡採用最尖端科技,能夠檢測多種健康狀況,例如青光眼和糖尿病。此外,它們還具備許多先進功能,例如能夠捕捉佩戴者眼部影像並適應不同的光照條件,從而最佳化從明亮環境到黑暗環境的過渡。主要企業持續投入巨資研發這些技術,以造福患有老齡化黃斑部病變等疾病的患者。市場需求的激增以及持續不斷的研發投入是推動市場擴張的關鍵因素。

限制全球智慧隱形眼鏡市場的因素

儘管糖尿病和青光眼等健康問題的發生率不斷上升,但全球智慧隱形眼鏡市場仍面臨許多挑戰,阻礙其廣泛普及。其中最主要的阻礙因素是潛在用戶對這項技術的了解不足。此外,智慧隱形眼鏡的高成本預計也會限制市場成長。然而,政府和非政府組織進行的宣傳活動,以及眾多新產品的推出,正在增加可供選擇的種類,並可能為市場擴張創造新的機遇,尤其是在發展中地區。

全球智慧隱形眼鏡市場趨勢

全球智慧隱形眼鏡市場正呈現蓬勃發展的趨勢,主要企業之間的策略聯盟日益增多。谷歌、SONY、三星和Innovega等領導者正攜手合作,強化產品線,加速這一新興領域的創新。目前,智慧隱形眼鏡產品線相對有限,這為市場成長和多元化發展創造了巨大機會。這些合作關係促進了資源共用、技術進步和研發加速,最終將催生出擴增實境(AR)整合和健康監測等前沿功能。這將激發消費者興趣,推動市場擴張。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 技術進步
  • 監管環境
  • 專利分析
  • 貿易分析

全球智慧隱形眼鏡市場規模(按類型及複合年成長率分類)(2026-2033 年)

  • 基於電極的透鏡
  • 基於感光元件的鏡頭
  • 其他

全球智慧隱形眼鏡市場規模(按應用領域分類)及複合年成長率(2026-2033 年)

  • 持續血糖監測
  • 眼內壓監測
  • 其他

全球智慧隱形眼鏡市場規模(按最終用戶分類)及複合年成長率(2026-2033 年)

  • 醫院
  • 診所
  • 居家醫療環境
  • 其他

全球智慧隱形眼鏡市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Roche(Switzerland)
  • GE Healthcare(United States)
  • Abbott Laboratories(United States)
  • Philips Healthcare(Netherlands)
  • Danaher Corporation(United States)
  • Quest Diagnostics(United States)
  • Fujifilm Medical(Japan)
  • Becton, Dickinson and Company(United States)
  • Siemens Healthineers(Germany)
  • Hologic Inc.(United States)
  • Grifols(Spain)
  • Beckman Coulter(United States)
  • bioMerieux(France)
  • Thermo Fisher Scientific(United States)
  • PerkinElmer(United States)
  • Illumina(United States)
  • Agilent Technologies(United States)
  • Bio-Rad Laboratories(United States)
  • Merck Group(Germany)

結論與建議

簡介目錄
Product Code: SQMIG35G2101

Global Smart Contact Lenses Market size was valued at USD 6.78 Billion in 2024 and is poised to grow from USD 7.41 Billion in 2025 to USD 15.09 Billion by 2033, growing at a CAGR of 9.3% during the forecast period (2026-2033).

The Smart Contact Lenses market is experiencing significant growth, driven by the rising demand for innovative healthcare solutions, particularly among diabetic patients. These advanced lenses measure glucose levels in tears and intraocular pressure while incorporating a wireless chip for data transmission, leveraging RFID technology for power extraction. Increased healthcare awareness, the aging population, and the prevalence of chronic diseases, including glaucoma and cataracts linked to diabetes, are key factors fueling market expansion. Moreover, the push for efficient and non-invasive diagnostic tools enhances attractiveness among users. Despite these favorable trends, high acquisition costs may hinder broader adoption. The continuing evolution of smart contact lens technology and investments from stakeholders are expected to positively influence market dynamics in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Contact Lenses market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Contact Lenses Market Segments Analysis

Global Smart Contact Lenses Market is segmented by Type, Application, End-User and region. Based on Type, the market is segmented into Electrodes-Based Lenses, Sensors-Based Lenses and Other. Based on Application, the market is segmented into Continuous Glucose Monitoring, Intraocular Pressure Monitoring and Others. Based on End-User, the market is segmented into Hospitals, Clinics, Homecare Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Contact Lenses Market

The global market for smart contact lenses is experiencing significant growth due to rapid advancements in the contact lens sector. Smart contact lenses represent a cutting-edge innovation, capable of detecting various health conditions such as glaucoma and diabetes. Furthermore, these lenses offer enhanced features, including the ability to capture images with the wearer's eyes and adapt to varying lighting conditions, ensuring optimal vision transitions from light to dark environments. Major companies continue to invest heavily in developing these technologies, particularly for individuals with conditions such as age-related macular degeneration. This surge in demand and ongoing research and development efforts are key factors propelling market expansion.

Restraints in the Global Smart Contact Lenses Market

The Global Smart Contact Lenses market faces several challenges that hinder its widespread adoption, despite the rising incidence of health issues like diabetes and glaucoma. A significant factor contributing to this restraint is the general lack of understanding about the technology among potential users. Additionally, the high cost associated with smart contact lenses is expected to limit market growth. However, initiatives by governmental and non-governmental organizations aimed at raising public awareness, along with numerous upcoming product launches, are anticipated to expand the variety of available options, potentially creating new opportunities for market expansion, especially in developing regions.

Market Trends of the Global Smart Contact Lenses Market

The Global Smart Contact Lenses market is witnessing a dynamic trend characterized by increasing strategic alliances between key industry players. As major companies like Google, Sony, Samsung, and Innovega Inc. collaborate, they aim to enhance their product lines and accelerate innovation in this emerging field. Currently, the smart contact lens portfolio is relatively limited, creating substantial opportunities for growth and diversification. These partnerships facilitate resource sharing, technological advancements, and accelerated research and development, ultimately leading to the introduction of cutting-edge features such as augmented reality integration and health monitoring capabilities, thereby driving consumer interest and market expansion.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Trade Analysis

Global Smart Contact Lenses Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Electrodes-Based Lenses
  • Sensors-Based Lenses
  • Other

Global Smart Contact Lenses Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Continuous Glucose Monitoring
  • Intraocular Pressure Monitoring
  • Others

Global Smart Contact Lenses Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Clinics
  • Homecare Settings
  • Others

Global Smart Contact Lenses Market Size & CAGR (2026-2033)

  • North America (Type, Application, End-User)
    • US
    • Canada
  • Europe (Type, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Roche (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Healthcare (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Medical (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Grifols (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beckman Coulter (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations